At KamTek, we provide ICH Q1A(R2)-compliant stability storage and testing to ensure your drug products or biologics meet global regulatory requirements. Drug Stability testing is a critical step in the drug development process, evaluating how environmental factors like temperature, humidity, and light impact the potency, safety, and shelf life of pharmaceutical products. We provide complete documentation throughout the study process and facilitate domestic and international shipping at predefined conditions to various labs for additional testing requirements.
What is ICH stability storage:
The ICH Stability Testing Guidelines (ICH Q1A(R2)) provide a harmonized framework for assessing the stability of new drug substances and drug products.
Stability testing is of three types:
Type |
Purpose |
Temperature |
Humidity |
Long-term testing |
Evaluates stability under normal storage conditions |
25°C ± 2°C |
60% RH ± 5% RH |
Accelerated testing |
Assesses degradation at higher temperatures and humidity |
40°C ± 2°C |
75% RH ± 5% RH |
Intermediate testing |
Conducte |
30°C ± 2°C |
65% RH ± 5% RH |
These tests are conducted with a testing frequency of 0, 3, 6, 9, 12, 18, and 24 months for long-term studies, with more frequent intervals for accelerated studies.
Stability tests are typically conducted on at least three primary batches of a drug using the proposed packaging.
KamTek’s Approach to Stability Testing
Our advanced stability chambers adhere to ICH Q1A(R2) guidelines and are designed to provide precise and reliable environmental control for drug stability studies. We ensure:
As our mission states, our primary goal is to bring success to your drug so that it effectively alleviates pain and improves the well-being of humans and animals.
KamTek provides stability testing not only for small molecule drug types or drug products, but also for peptides, vaccines, medical devices, biologics etc.
We offer stability testing at a range of conditions, including:
Why Stability Testing Matters
Stability testing is essential for regulatory approval and ensures that drugs maintain their intended efficacy over time. It supports:
How Stability Testing Helps in Drug Clearance for Trials
Regulatory agencies such as the FDA, EMA, and other global authorities require stability data as part of Investigational New Drug (IND) and New Drug Application (NDA) submissions.
Stability studies help demonstrate that a drug remains effective and safe throughout clinical trials, streamlining the approval process.
Why Choose KamTek for Your Stability Testing Needs?